PHILADELPHIA -Genetically modified versions of patients’ own immune cells successfully traveled to tumors they were designed to attack in an early-stage trial for mesothelioma and pancreatic and ovarian cancers at the Perelman School of Medicine at the University of P…
Source: Investigational personalized cellular therapy tolerated well by patients
Sunday, April 19, 2015
Investigational personalized cellular therapy tolerated well by patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment